Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-18-010043
Filing Date
2018-05-15
Accepted
2018-05-15 17:23:38
Documents
1
Period of Report
2018-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1909
  Complete submission text file 0001437749-18-010043.txt   3264
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 27/F TWO EXCHANGE SQUARE 8 CONNAUGHT PLACE CENTRAL K3 00000
Business Address
Liu Yanbin (Reporting) CIK: 0001740506 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33678 | Film No.: 18837887